OFM
Omega Fund Management Portfolio holdings
AUM
$154M
1-Year Return
32.78%
This Quarter Return
-9.29%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$707M
AUM Growth
-$184M
(-21%)
Cap. Flow
-$65.6M
Cap. Flow
% of AUM
-9.28%
Top 10 Holdings %
Top 10 Hldgs %
88.63%
Holding
27
New
1
Increased
–
Reduced
5
Closed
5
Top Buys
| 1 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$9.02M |
Top Sells
| 1 |
Nuvation Bio
NUVB
|
$44.7M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$5.77M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$5.49M |
| 4 |
Cidara Therapeutics
CDTX
|
$4.49M |
| 5 |
Replimune Group
REPL
|
$3.6M |
Sector Composition
| 1 | Healthcare | 99.31% |
| 2 | Financials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Trevi Therapeutics
TRVI
$880M
| – | – |
-1,263,408
| Closed | -$1.77M |
|
|
OBSV
27
DELISTED
ObsEva SA Ordinary Shares
OBSV
| – | – |
-999,364
| Closed | -$3.11M |
|